MX359104B - Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos. - Google Patents

Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.

Info

Publication number
MX359104B
MX359104B MX2016011682A MX2016011682A MX359104B MX 359104 B MX359104 B MX 359104B MX 2016011682 A MX2016011682 A MX 2016011682A MX 2016011682 A MX2016011682 A MX 2016011682A MX 359104 B MX359104 B MX 359104B
Authority
MX
Mexico
Prior art keywords
combination therapy
different antibiotics
therapy together
polymyxin derivatives
iii
Prior art date
Application number
MX2016011682A
Other languages
English (en)
Other versions
MX2016011682A (es
Inventor
Brown Pamela
Dawson Michael
Simonovic Mona
Boakes Steven
Duperchy Esther
James Stanway Steven
Wilson Antoinette
Frederick Moss Stephen
Original Assignee
New Pharma Licence Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB201404301A external-priority patent/GB201404301D0/en
Priority claimed from GB201421019A external-priority patent/GB201421019D0/en
Application filed by New Pharma Licence Holdings Ltd filed Critical New Pharma Licence Holdings Ltd
Publication of MX2016011682A publication Critical patent/MX2016011682A/es
Publication of MX359104B publication Critical patent/MX359104B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a compuestos de la fórmula (III), y el uso de compuestos de la fórmula (III) en métodos de tratamiento, tal como métodos de tratamiento de una infección microbiana. Los compuestos de la fórmula (III) son: (ver Fórmula) donde -R15 es un grupo que contiene amino: (ver Fórmula) y -R1, -R2, -R3, -R4, -R8, -RA, Q, -R16, -R17 son como se ha explicado en mayor detalle en la descripción.
MX2016011682A 2014-03-11 2015-03-11 Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos. MX359104B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB201404301A GB201404301D0 (en) 2014-03-11 2014-03-11 Compounds and combinations
GB201421019A GB201421019D0 (en) 2014-11-26 2014-11-26 Compounds
PCT/EP2015/055046 WO2015135976A1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics

Publications (2)

Publication Number Publication Date
MX2016011682A MX2016011682A (es) 2017-04-27
MX359104B true MX359104B (es) 2018-09-14

Family

ID=52823596

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016011682A MX359104B (es) 2014-03-11 2015-03-11 Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.

Country Status (20)

Country Link
US (3) US20170073373A1 (es)
EP (1) EP3116897B1 (es)
JP (1) JP6785659B2 (es)
KR (2) KR20230152779A (es)
CN (1) CN106232617B (es)
AU (1) AU2015228898B2 (es)
CA (1) CA2940455C (es)
DK (1) DK3116897T3 (es)
ES (1) ES2910072T3 (es)
HR (1) HRP20220387T1 (es)
IL (1) IL247243B (es)
LT (1) LT3116897T (es)
MX (1) MX359104B (es)
PL (1) PL3116897T3 (es)
PT (1) PT3116897T (es)
RS (1) RS63138B1 (es)
RU (1) RU2740190C2 (es)
SI (1) SI3116897T1 (es)
TW (1) TWI709575B (es)
WO (1) WO2015135976A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2780357A1 (en) * 2011-11-18 2014-09-24 Novacta Biosystems Limited Polymyxin derivatives
NZ724798A (en) 2014-04-01 2020-05-29 Univ Monash Polymyxin derivatives as antimicrobial compounds
CN107257803B (zh) 2014-12-16 2021-02-05 上海盟科药业股份有限公司 用于治疗细菌感染的多粘菌素类抗菌剂
CN105030744B (zh) * 2015-07-09 2019-04-19 广州英赛特生物技术有限公司 取代苯胍衍生物作为多粘菌素类抗生素增效剂的应用
CN108350034B (zh) * 2015-09-29 2022-03-11 莫纳什大学 抗微生物的多黏菌素衍生的化合物
JP6744622B2 (ja) * 2016-06-16 2020-08-19 学校法人上智学院 ピペリジン化合物の製造方法
JP2021501783A (ja) * 2017-11-02 2021-01-21 ザ ユニバーシティー オブ クイーンズランド ペプチド抗生物質
HRP20240028T1 (hr) 2018-06-25 2024-03-29 Spero Therapeutics, Inc. Spojevi
CN111690040A (zh) * 2019-03-12 2020-09-22 上海来益生物药物研究开发中心有限责任公司 多粘菌素衍生物、其制备方法和应用
US20230141981A1 (en) 2020-01-21 2023-05-11 Shanghai Micurx Pharmaceuticals Co., Ltd Novel compounds and composition for targeted therapy of kidney-associated cancers
TW202233649A (zh) 2020-11-06 2022-09-01 美商斯佩羅治療學股份有限公司 化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
HUE028271T2 (en) * 2006-08-11 2016-12-28 Northern Antibiotics Oy Polymixin derivatives and their applications
AR074874A1 (es) * 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
CN101851270A (zh) * 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
US8415307B1 (en) * 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012168820A1 (en) * 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
EP2780357A1 (en) * 2011-11-18 2014-09-24 Novacta Biosystems Limited Polymyxin derivatives
WO2014188178A1 (en) * 2013-05-22 2014-11-27 Cantab Anti-Infectives Limited Polymyxin derivatives and their use in combination therapy together with different antibiotics

Also Published As

Publication number Publication date
SI3116897T1 (sl) 2022-06-30
MX2016011682A (es) 2017-04-27
PT3116897T (pt) 2022-04-07
TW201617362A (zh) 2016-05-16
DK3116897T3 (da) 2022-03-28
US20210221848A1 (en) 2021-07-22
EP3116897A1 (en) 2017-01-18
RS63138B1 (sr) 2022-05-31
LT3116897T (lt) 2022-05-10
CA2940455C (en) 2023-03-21
AU2015228898B2 (en) 2018-11-15
KR20160135739A (ko) 2016-11-28
RU2740190C2 (ru) 2021-01-12
CN106232617B (zh) 2022-06-24
EP3116897B1 (en) 2022-03-02
US20170073373A1 (en) 2017-03-16
CA2940455A1 (en) 2015-09-17
IL247243A0 (en) 2016-09-29
IL247243B (en) 2020-04-30
HRP20220387T1 (hr) 2022-05-27
CN106232617A (zh) 2016-12-14
AU2015228898A1 (en) 2016-10-20
WO2015135976A1 (en) 2015-09-17
TWI709575B (zh) 2020-11-11
ES2910072T3 (es) 2022-05-11
KR20230152779A (ko) 2023-11-03
PL3116897T3 (pl) 2022-05-30
RU2016139978A3 (es) 2018-10-17
RU2016139978A (ru) 2018-04-13
JP2017510570A (ja) 2017-04-13
JP6785659B2 (ja) 2020-11-18
US20230322858A1 (en) 2023-10-12

Similar Documents

Publication Publication Date Title
MX359104B (es) Derivados de polimixina y su uso en terapia de combinacion junto con diferentes antibioticos.
CA2909335C (en) Fenfluramine for use in the treatment of dravet syndrome
NZ713621A (en) Compounds and methods of treating infections
WO2014188178A9 (en) Polymyxin derivatives and their use in combination therapy together with different antibiotics
EP3505620A4 (en) 2D ORGANOID FOR INFECTIONS AND GROWTH OF HUMAN DIARRHOEVIRUS AND USE OF THE TWO-DIMENSIONAL ORGANOID
WO2015003816A3 (en) Cystobactamides
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
MX2023000418A (es) Fluorofenil beta-hidroxietilaminas y su uso en el tratamiento de la hiperglucemia.
MX2016009251A (es) Derivados de 7-oxo-1, 6-diazabiciclo [3.2.1] octano y su uso como agentes antibacterianos.
MX2017000312A (es) Derivados de isoindolina para usarse en el tratamiento de una infeccion viral.
MX2015016319A (es) Terapia de combinacion que comprende oxazolidinona-quinolonas para uso en el tratamiento de infecciones bacterianas.
AU2015352440B2 (en) Compounds
EA201591362A1 (ru) Соединения и способы лечения бактериальных инфекций
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
MA40535A (fr) Imagerie et thérapie d'une inflammation et d'une infection ciblant hsp90
MX2017009094A (es) Derivado de polimixina y usos del mismo.
EP3856213A4 (en) METHOD OF TREATMENT OF INFECTIONS USING BACTERIA
CL2015002759A1 (es) Métodos de tratamiento de infecciones en pacientes con sobrepeso y obesos usando antibióticos
PL3497095T3 (pl) Związki chelatujące cynk do stosowania w leczeniu zakażenia bakteryjnego
EP3285787B8 (en) Treatment of bacterial infections in aquaculture
IL281780A (en) History of indan for the treatment of bacterial infection
IN2013MU03216A (es)
EA201990995A1 (ru) Терапия постоперационной рвоты амисульпридом
SG10201903630UA (en) Iminosugars useful for the treatment of viral diseases
WO2016072854A3 (en) Pantothenamide analogues

Legal Events

Date Code Title Description
FG Grant or registration